Production and the characterization of monoclonal antibody against CD43, K06

W S Park1, J S Chae, K C Jung

  • 1Department of Pathology, Kangwon National University College of Medicine, Chuncheon, Korea.

Tissue Antigens
|December 4, 2003
PubMed

Insights

A new monoclonal antibody, K06, recognizes a novel epitope on the CD43 molecule. This K06 epitope

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD43 is a transmembrane glycoprotein expressed on various hematopoietic cells.
  • Understanding CD43 epitopes is crucial for cell differentiation and immune responses.

Purpose of the Study:

  • To characterize a novel monoclonal antibody, K06, targeting human CD43.
  • To investigate the expression and function of the K06-defined CD43 epitope.

Main Methods:

  • Development and characterization of anti-CD43 monoclonal antibody K06.
  • Immunohistochemical analysis of lymphoid organs and peripheral blood.
  • Biochemical analysis of CD43 antigen.
  • Apoptosis induction studies in leukemic cell lines.

Main Results:

  • K06 antibody recognizes a novel CD43 epitope with distinct reactivity patterns in lymphoid organs.
  • The K06 epitope is highly expressed on cortical thymocytes, platelets, and myeloid cells.
  • Biochemical studies show K06 recognizes a glycosylated moiety of CD43.
  • CD43 ligation via the K06 epitope induces apoptosis in Molt-4 cells.

Conclusions:

  • The K06 antibody identifies a novel CD43 epitope with potential roles in T-cell development.
  • This epitope may be involved in regulating apoptosis in certain cell types.